Oncology

This study involves an investigational cellular therapy called Afamitresgene Autoleucel.

The Behavioral Oncology Program aims to improve the medical and psychosocial outcomes and health-related quality of life in young patients and their families across the continuum of cancer care.

This study is for people with growing abnormal lymph vessels called lymphatic malformations (LMs).

The Program in Advanced Imaging Research provides state-of-the-art advanced neuroscience and body imaging capabilities to support the world-class investigators at Children’s Hospital of Philadelphia in advancing novel discovery and translational research findings.

This study has several parts and involves taking a study drug called alpelisib.

The overall goal of this study is to find out if the study drug is safe and effective at treating adults and children with relapsed or refractory acute myeloid leukemia (R/R AML), high risk myelodysplastic syndrome (HR-MDS), or B-cell acute lymphoblastic leukemia (B-ALL).

This study enrolls patients that have been diagnosed with osteosarcoma or neuroblastoma that has come back (relapsed) or has not responded to standard treatments (refractory).